Professor of Surgery at the University of Minnesota
Scientific Director of the Diabetes Institute for Immunology and Transplantation
Director of the Islet Transplant Program
Holder of the Eunice L. Dwan Diabetes Research Chair
Bernhard J. Hering, M.D. is widely regarded as the foremost expert on islet transplantation. He is the medical director of the Collaborative Islet Transplant Registry (CITR), and has also served as president of the Cell Transplant Society and as councilor of the International Pancreas and Islet Transplant Association. Dr. Hering also serves on steering committees of major clinical research programs in transplantation and diabetes such as the National Institutes of Health (NIH) Immune Tolerance Network, the Type 1 Diabetes TrialNet, and the Clinical Islet Transplant Consortium, which is the largest ever funded research activity in islet transplantation ($75 million over five years). The major objective of this consortium is to complete the translation of islet transplantation from clinical research to clinical care. The Diabetes Institute for Immunology and Transplantation is one of five centers in the world selected by the NIH to conduct and analyze studies of islet transplantation in patients with type 1 diabetes.
Curriculum Vitae (.pdf)
©2002 Regents of the University of Minnesota. All rights reserved.
The University of Minnesota is an equal opportunity educator and employer.
Last modified on Thursday Sep 16, 2004
This page is located at http://www.med.umn.edu//diabinst/team/hering.html